- SEK2.07bn
- SEK6.63bn
- SEK10.30bn
- 75
- 85
- 95
- 99
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.4 | ||
| PEG Ratio (f) | 0.3 | ||
| EPS Growth (f) | 32.77% | ||
| Dividend Yield (f) | 3.79% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.66 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 3.42 | ||
| Price to Sales | 0.2 | ||
| EV to EBITDA | 5.93 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.72% | ||
| Return on Equity | 6.5% | ||
| Operating Margin | 4.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 7,797 | 8,188 | 9,241 | 9,649 | 10,296 | 9,754.8 | 10,808.5 | 6.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +26.75 | +18.42 | -23.99 | -23.43 | +8.06 | +28.65 | +39.64 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Humana AB is a Sweden-based care provider. It operates through four segments: Individual & Family, Personal Assistance, Elderly Care and Other Nordics. The Individual & Family segment provides psychosocial disorders and mental illness care. The Personal Assistance segment provides personal assistance to people with functional disabilities. The Elderly Care segment provides housing for the elderly. The Other Nordics segment covers the Company’s developing market operations in the area. It operates in Sweden, Norway, Finland and Denmark.
Directors
- Soren Mellstig NEC (69)
- Noora Jayasekara CFO (43)
- Helena Pharmanson DMK (54)
- Anna Giertz Skablova DHR (50)
- Anders Broberg OTH (51)
- Anu Kallio OTH (52)
- Mona Lien OTH (58)
- Eva Nilsson Bagenholm OTH (60)
- Johanna Rastad OTH (40)
- Andreas Westlund OTH (42)
- Karita Bekkemellem IND (56)
- Kirsi Komi IND (58)
- Monica Lingegard IND (58)
- Anders Nyberg IND (65)
- Fredrik Stromholm IND (55)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- July 1st, 2008
- Public Since
- March 22nd, 2016
- No. of Shareholders
- 5,891
- No. of Employees
- 11,127
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm- Shares in Issue
- 51,826,058
- Address
- Warfvinges vag 39, 7tr, STOCKHOLM, 112 51
- Web
- https://www.humana.se/
- Phone
- +46 859929900
- Contact
- Ewelina Pettersson
- Auditors
- KPMG AB
Upcoming Events for HUM
Dividend For HUMAN.ST - 1.0000 SEK
Humana AB Annual Shareholders Meeting
Q2 2025 Humana AB Earnings Release
Q3 2025 Humana AB Earnings Release
Similar to HUM
Ambea AB (publ)
OMX Nordic Exchange Stockholm
Attendo AB (publ)
OMX Nordic Exchange Stockholm
Medhelp Care AB (publ)
OMX Nordic Exchange Stockholm
Medicover AB
OMX Nordic Exchange Stockholm
Prostatype Genomics AB
OMX Nordic Exchange Stockholm
FAQ
What is the Humana AB share price?
As of Today at 21:10 UTC, shares in Humana AB are trading at SEK39.85. This share price information is delayed by 15 minutes.
How has the Humana AB share price performed this year?
Shares in Humana AB last closed at SEK39.85 and the price had moved by +43.09% over the past 365 days. In terms of relative price strength the Humana AB share price has outperformed the FTSE Global All Cap Index by +39.51% over the past year.
What are the analyst and broker recommendations for Humana AB?
The overall consensus recommendation for Humana AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Humana AB dividend yield?
The Humana AB dividend yield is 2.51% based on the trailing twelve month period.
Does Humana AB pay a dividend?
Last year, Humana AB paid a total dividend of SEK1.00, and it currently has a trailing dividend yield of 2.51%.Looking ahead, shares in Humana AB are due to go ex-dividend on 2025-05-07 and the next dividend pay date is 2025-05-13.
When does Humana AB next pay dividends?
Humana AB are due to go ex-dividend on 2025-05-07 and the next dividend pay date is 2025-05-13. The historic dividend yield on Humana AB shares is currently 2.51%.
How do I buy Humana AB shares?
To buy shares in Humana AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Humana AB?
As of the previous close price of SEK39.85, shares in Humana AB had a market capitalisation of SEK2.07bn.
Where are Humana AB shares listed?
Here are the trading details for Humana AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: HUM
What kind of share is Humana AB?
Based on an overall assessment of its quality, value and momentum Humana AB is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Humana AB share price forecast for 2025?
The analyst consensus target price for shares in Humana AB is SEK50.25. That is 26.1% above the last closing price of SEK39.85.
Analysts covering Humana AB currently have a consensus Earnings Per Share (EPS) forecast of SEK4.78 for the next financial year.
Find out moreWhat is the trend in the Humana AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Humana AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +2.7%.
As of the last closing price of SEK39.85, shares in Humana AB were trading +6.84% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Humana AB PE Ratio?
The Humana AB PE ratio based on its reported earnings over the past 12 months is 7.4. The shares last closed at SEK39.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Humana AB?
Humana AB's management team is headed by:
- Soren Mellstig - NEC
- Noora Jayasekara - CFO
- Helena Pharmanson - DMK
- Anna Giertz Skablova - DHR
- Anders Broberg - OTH
- Anu Kallio - OTH
- Mona Lien - OTH
- Eva Nilsson Bagenholm - OTH
- Johanna Rastad - OTH
- Andreas Westlund - OTH
- Karita Bekkemellem - IND
- Kirsi Komi - IND
- Monica Lingegard - IND
- Anders Nyberg - IND
- Fredrik Stromholm - IND